PEO1 and PEO4 are part of our validated ovarian adenocarcinoma cell lines derived from patients at varying stages of cancer and treatment. These models can be used to better understand mechanisms of oestrogen action, as well as efficacy and toxicity of oestrogen protagonists in ovarian adenocarcinoma. They have been used to generate rich preclinical data and to optimise drug discovery pipelines, including target validation and drug screening.
PEO1 and PEO4 cell lines
For our commercial customers
Our dedicated licensing team can assist you in any of your commercial enquiries and help to guide you in identifying the right license for your needs. We support partners in the Pharma, Biotechnology and CRO/CDMO industries. Please contact us below: